Abstract
In melanoma, intratumoral T-VEC is thought to work through viral replication and destruction of cancer cells, thereby stimulating an immune response. In this issue of Cancer Cell, Ramelyte et al. show activity of T-VEC in cutaneous B cell lymphoma and demonstrate, using scRNA-seq, that viral replication occurs not only in tumor cells.